Biocon raises Rs 1070 crore through NCDs

22 Feb 2023 Evaluate

Biocon has raised Rs 1070 crore through allotment of 1,07,000 unlisted, secured, rated, redeemable, non-convertible debentures (NCDs) of face value of Rs 1,00,000 each on private placement basis in 3 series. Date of maturity of the said NCDs will be on February 21, 2028.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

377.55 -1.50 (-0.40%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×